Evaluation of gaps in direct oral anticoagulants (DOACs) management in an outpatient underserved clinic: a cross-sectional study

Abstract DOACs are widely used for stroke prevention in non-valvular atrial fibrillation and treatment of thromboembolism, but gaps in their management can lead to adverse outcomes. In outpatient, underserved clinics, challenges such as inappropriate dosing, lack of monitoring, and improper drug com...

Full description

Saved in:
Bibliographic Details
Main Authors: Bader M. Alghamdi, Sara L. Rogers
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-07712-0
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849238423673503744
author Bader M. Alghamdi
Sara L. Rogers
author_facet Bader M. Alghamdi
Sara L. Rogers
author_sort Bader M. Alghamdi
collection DOAJ
description Abstract DOACs are widely used for stroke prevention in non-valvular atrial fibrillation and treatment of thromboembolism, but gaps in their management can lead to adverse outcomes. In outpatient, underserved clinics, challenges such as inappropriate dosing, lack of monitoring, and improper drug combinations may be more pronounced, necessitating evaluation to optimize patient care and reduce risks. This study assessed the appropriateness of DOAC use and dosing per FDA guidelines, considering renal function, hepatic function, and drug–drug interactions. Secondary objectives focused on evaluating inappropriate aspirin use alongside DOACs. This was a single-center retrospective cohort study. The study was conducted at Texas A&M Health Family Care Clinic (12/24/2022–12/24/2023). Older than 18 years of age and had active prescription of DOAC (apixaban, dabigatran, edoxaban, or rivaroxaban). A total of 125 DOAC patients were included. Inappropriate dosing based on renal function occurred in 16% of cases. DOAC use was unsuitable in two patients with severe hepatic impairment. Major drug interactions resulted in two instances of inappropriate DOAC use. Additionally, about 61% of aspirin usage involved inappropriate combinations with DOACs, as shown in Fig. 1. The study’s findings indicate that anticoagulation management in our ambulatory care setting has the potential for further optimization.
format Article
id doaj-art-e946599b35724a9bb813c00d6aae4bf4
institution Kabale University
issn 2045-2322
language English
publishDate 2025-07-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-e946599b35724a9bb813c00d6aae4bf42025-08-20T04:01:36ZengNature PortfolioScientific Reports2045-23222025-07-011511610.1038/s41598-025-07712-0Evaluation of gaps in direct oral anticoagulants (DOACs) management in an outpatient underserved clinic: a cross-sectional studyBader M. Alghamdi0Sara L. Rogers1Department of Clinical Pharmacy, College of Pharmacy, Al-Baha UniversityDepartment of Pharmacy Practice, Texas A&M Irma Lerma Rangel College of PharmacyAbstract DOACs are widely used for stroke prevention in non-valvular atrial fibrillation and treatment of thromboembolism, but gaps in their management can lead to adverse outcomes. In outpatient, underserved clinics, challenges such as inappropriate dosing, lack of monitoring, and improper drug combinations may be more pronounced, necessitating evaluation to optimize patient care and reduce risks. This study assessed the appropriateness of DOAC use and dosing per FDA guidelines, considering renal function, hepatic function, and drug–drug interactions. Secondary objectives focused on evaluating inappropriate aspirin use alongside DOACs. This was a single-center retrospective cohort study. The study was conducted at Texas A&M Health Family Care Clinic (12/24/2022–12/24/2023). Older than 18 years of age and had active prescription of DOAC (apixaban, dabigatran, edoxaban, or rivaroxaban). A total of 125 DOAC patients were included. Inappropriate dosing based on renal function occurred in 16% of cases. DOAC use was unsuitable in two patients with severe hepatic impairment. Major drug interactions resulted in two instances of inappropriate DOAC use. Additionally, about 61% of aspirin usage involved inappropriate combinations with DOACs, as shown in Fig. 1. The study’s findings indicate that anticoagulation management in our ambulatory care setting has the potential for further optimization.https://doi.org/10.1038/s41598-025-07712-0Anticoagulant agentOutpatient careQuality improvement
spellingShingle Bader M. Alghamdi
Sara L. Rogers
Evaluation of gaps in direct oral anticoagulants (DOACs) management in an outpatient underserved clinic: a cross-sectional study
Scientific Reports
Anticoagulant agent
Outpatient care
Quality improvement
title Evaluation of gaps in direct oral anticoagulants (DOACs) management in an outpatient underserved clinic: a cross-sectional study
title_full Evaluation of gaps in direct oral anticoagulants (DOACs) management in an outpatient underserved clinic: a cross-sectional study
title_fullStr Evaluation of gaps in direct oral anticoagulants (DOACs) management in an outpatient underserved clinic: a cross-sectional study
title_full_unstemmed Evaluation of gaps in direct oral anticoagulants (DOACs) management in an outpatient underserved clinic: a cross-sectional study
title_short Evaluation of gaps in direct oral anticoagulants (DOACs) management in an outpatient underserved clinic: a cross-sectional study
title_sort evaluation of gaps in direct oral anticoagulants doacs management in an outpatient underserved clinic a cross sectional study
topic Anticoagulant agent
Outpatient care
Quality improvement
url https://doi.org/10.1038/s41598-025-07712-0
work_keys_str_mv AT badermalghamdi evaluationofgapsindirectoralanticoagulantsdoacsmanagementinanoutpatientunderservedclinicacrosssectionalstudy
AT saralrogers evaluationofgapsindirectoralanticoagulantsdoacsmanagementinanoutpatientunderservedclinicacrosssectionalstudy